X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (86) 86
humans (85) 85
malaria (67) 67
tanzania (51) 51
female (48) 48
infectious diseases (48) 48
infant (47) 47
child, preschool (45) 45
parasitic diseases (45) 45
male (42) 42
research (42) 42
tanzania - epidemiology (38) 38
child (36) 36
tropical medicine (36) 36
adolescent (34) 34
parasitology (32) 32
children (31) 31
adult (29) 29
malaria, falciparum - epidemiology (28) 28
animals (26) 26
prevalence (22) 22
abridged index medicus (21) 21
malaria, falciparum - prevention & control (21) 21
parasites (21) 21
health aspects (20) 20
plasmodium falciparum (20) 20
vector-borne diseases (20) 20
epidemiology (19) 19
infectious and parasitic diseases (19) 19
arctic medicine. tropical medicine (17) 17
infant, newborn (17) 17
malaria, falciparum - parasitology (17) 17
young adult (17) 17
antimalarials - therapeutic use (16) 16
plasmodium-falciparum (16) 16
research article (16) 16
transmission (16) 16
cross-sectional studies (15) 15
immunology (15) 15
plasmodium falciparum - immunology (15) 15
drug resistance (14) 14
medical research (14) 14
risk factors (14) 14
africa (13) 13
drug therapy (13) 13
hiv (13) 13
malaria, falciparum - immunology (13) 13
mortality (13) 13
public health (13) 13
public, environmental & occupational health (13) 13
studies (13) 13
antibodies, protozoan - blood (12) 12
plasmodium falciparum - drug effects (12) 12
resistance (12) 12
surveillance, monitoring, evaluation (12) 12
analysis (11) 11
disease transmission (11) 11
drug combinations (11) 11
incidence (11) 11
infections (11) 11
malaria vaccine (11) 11
malaria, falciparum - transmission (11) 11
medicine (11) 11
middle aged (11) 11
plasmodium-falciparum malaria (11) 11
population (11) 11
prevention (11) 11
tropical diseases (11) 11
usage (11) 11
vaccines (11) 11
anemia (10) 10
diagnosis (10) 10
efficacy (10) 10
genetic aspects (10) 10
infants (10) 10
infection (10) 10
microscopy (10) 10
morbidity (10) 10
rural population (10) 10
safety (10) 10
sulfadoxine-pyrimethamine (10) 10
hospitals (9) 9
human diseases (9) 9
malaria vaccines - immunology (9) 9
malaria, falciparum - drug therapy (9) 9
mutation (9) 9
plasmodium falciparum - genetics (9) 9
polymerase chain reaction (9) 9
pregnancy (9) 9
protozoan proteins - immunology (9) 9
amodiaquine (8) 8
antimalarials (8) 8
artemether-lumefantrine (8) 8
care and treatment (8) 8
community (8) 8
dihydrofolate reductase (8) 8
drugs (8) 8
plasmodium falciparum - isolation & purification (8) 8
prospective studies (8) 8
science (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Malaria Journal, ISSN 1475-2875, 2010, Volume 9, Issue 1, pp. 216 - 216
Journal Article
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9700, pp. 1521 - 1532
Journal Article
MALARIA JOURNAL, ISSN 1475-2875, 07/2018, Volume 17, Issue 1, pp. 261 - 261
Journal Article
Journal Article
Malaria Journal, ISSN 1475-2875, 2011, Volume 10, Issue 1, pp. 6 - 6
Background: Malaria prevalence has recently declined markedly in many parts of Tanzania and other sub-Saharan African countries due to scaling-up of control... 
HEALTH LABORATORIES | POLYMERASE-CHAIN-REACTION | QUALITY | PLASMODIUM-FALCIPARUM | STAINED THICK | DIHYDROFOLATE-REDUCTASE | RESISTANCE | TANZANIA | FILTER-PAPER | PARASITOLOGY | TROPICAL MEDICINE | BLOOD | Tanzania - epidemiology | Prevalence | DNA, Protozoan - isolation & purification | Humans | Plasmodium - genetics | Specimen Handling - methods | Malaria - diagnosis | Polymerase Chain Reaction - methods | Diagnostic Tests, Routine | Parasitic Sensitivity Tests - methods | Malaria - epidemiology | Malaria - parasitology | Parasitology - methods | DNA, Protozoan - genetics | Plasmodium | Usage | Control | Malaria | Causes of | Physiological aspects | Genetic aspects | Research | Genetic screening | Methods | Chlorproguanil | Erythrocytes | Dapsone | Nucleotides | Drug resistance | Dehydrogenase | Epidemiology | Blood | Proteins | Quality assurance | Acquired immune deficiency syndrome--AIDS | Temperature effects | Technology | Villages | Dihydrofolate reductase | Species | Deoxyribonucleic acid--DNA | Testing | Availability | Medical research | Antigens | Enzymes | Rural areas | Anemia | Mortality | Studies | Storage | Antimalarial agents | Quality control | Monoclonal antibodies | Amodiaquine | Drugs | Temperature | Anaemia | Chloroquine | Genes | Artemisinin | Transmission | Clinical trials | Antibodies | Infections | Parasites | Tests | Accuracy | Antigenicity | Quality | Children | Enzyme-linked immunosorbent assay | Coloration | Communication | Vector-borne diseases | Preservatives | Management | Sensitivity | Fixation | Microscopy | Artemether | Medical wastes | Interactions | Gene mapping | Index Medicus
Journal Article
09/2013
Lymphatic filariasis (LF) is among the poverty related neglected tropical diseases earmarked for elimination using mass drug administration (MDA) strategy.... 
lymphatic filariasis | insecticide mosquito nets | Tanzania | Diethylcarbamazine
Web Resource
MALARIA JOURNAL, ISSN 1475-2875, 10/2018, Volume 17, Issue 1, pp. 369 - 369
BackgroundArtemisinin-based combination therapy (ACT) is the first-line anti-malarial treatment of uncomplicated malaria in most malaria endemic countries,... 
INFECTIOUS DISEASES | Malaria | Piperaquine | ARTEMETHER-LUMEFANTRINE | Artemisinin | Tanzania | Efficacy | PREVALENCE | PLASMODIUM-FALCIPARUM MALARIA | TROPICAL MEDICINE | CHILDREN | Molecular markers | POLYMORPHISMS | DIHYDROARTEMISININ-PIPERAQUINE | UNCOMPLICATED MALARIA | PROVINCES | Safety | MULTIDRUG-RESISTANCE | Artemisinin-based combination therapy | ASSOCIATION | PARASITOLOGY | Antimalarials - adverse effects | Malaria, Falciparum - prevention & control | Artemether, Lumefantrine Drug Combination - adverse effects | Prospective Studies | Humans | Child, Preschool | Infant | Male | Antimalarials - therapeutic use | Plasmodium falciparum - drug effects | Artemisinins - therapeutic use | Adolescent | Amodiaquine - adverse effects | Female | Quinolines - therapeutic use | Amodiaquine - therapeutic use | Artemether, Lumefantrine Drug Combination - therapeutic use | Artemisinins - adverse effects | Child | Drug Combinations | Quinolines - adverse effects | Research | Drug therapy | Analysis | Public health law | Therapy | Protocols | Endemic species | Countries | Erythrocytes | Parasites | Acquired immune deficiency syndrome--AIDS | Artesunate | Public health | Dihydroartemisinin | Vector-borne diseases | Mutations | Human diseases | Nucleotide sequence | Patients | Mutants | Polymerase chain reaction | Studies | Samples | DNA | Organizations | Alleles | Amodiaquine | Artemether | Mutation | Index Medicus | provinces | Parasitology | dihydroartemisinin-piperaquine | association | Klinisk medicin | plasmodium-falciparum malaria | polymorphisms | Clinical Medicine | prevalence | artemether-lumefantrine | multidrug-resistance | children | uncomplicated malaria | Infectious Diseases | Tropical Medicine
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2008, Volume 359, Issue 24, pp. 2521 - 2532
Journal Article
Malaria Journal, ISSN 1475-2875, 08/2017, Volume 16, Issue 1, pp. 308 - 308
Journal Article
Malaria Journal, ISSN 1475-2875, 07/2018, Volume 17, Issue 1, pp. 252 - 252
Journal Article